Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Infectious Disease
Neuro-immunology
Questions discussed in this category
Does management of NMDA receptor encephalitis change in a patient with HIV/AIDS?
1 Answer available
Do you recommend continuous antibiotic prophylaxis for patients on complement inhibitors such as eculizumab?
Do you just use antibiotic prophylaxis if therapy is started prior to meningococcal vaccination?
3 Answers available
How do you approach the timing of COVID-19 vaccination for patients with multiple sclerosis on B-cell depleting therapies?
3 Answers available
When would you consider checking JC virus prior to initiating biologic therapy?
1 Answer available
Do you treat HIV/AIDS-associated CNS vasculitis with antiretrovirals alone or in combination with steroids?
1 Answer available
17350
14128
9985
11145
8827
Papers discussed in this category
Neurology, 2020 Jul 29
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.
Cells, 2018 Dec 28
Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients.
Journal of neurovirology, 2018-06
Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.
Clin Microbiol Infect, 2018 Feb 07
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction).
Blood, 2020 Jun 18
Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Related Topics in Infectious Disease
Breast Cancer
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Gastrointestinal Cancers
Pediatric Hematology/Oncology
Sarcoma
Thoracic Malignancies
Bladder Cancer
Medical Oncology